TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vectus Biosystems Limited ( (AU:VBS) ) has shared an update.
Vectus Biosystems Limited announced the issuance of 25,000 ordinary fully paid securities to be quoted on the ASX, effective March 12, 2025. This move is part of the company’s strategy to enhance its financial flexibility and support its ongoing research and development efforts, potentially strengthening its market position and offering value to stakeholders.
More about Vectus Biosystems Limited
Vectus Biosystems Limited operates in the biotechnology industry, focusing on the development of therapeutic solutions. The company is primarily engaged in creating treatments for fibrosis and high blood pressure, aiming to address significant unmet medical needs in these areas.
YTD Price Performance: -6.25%
Average Trading Volume: 27,809
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$3.99M
See more insights into VBS stock on TipRanks’ Stock Analysis page.